Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether treatment with a drug called Simvastatin
prevents and improves outcome in patients who have Subarachnoid bleeding. Simvastatin is
currently approved for the treatment of high cholesterol levels.